BSECompany Update7 Oct 2026 · 7 Oct 2026, 06:47 pm
CERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS, 2018 FOR THE QUARTER ENDED 30.09.2026
Beryl Drugs Ltd · 524606
✦ AI SummaryRegulatory
Beryl Drugs Ltd has filed reports for the quarter ended 30.09.2026, including a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, and a non-applicability certificate under Regulation 57(5).
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk2/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Beryl Drugs Ltd - 524606 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Attachments (1)
📄pdf
Download →
28e3365f-85ce-4c80-8e62-279e8240fc7d.pdf
View document text
BERYL.
orves tures
TR ee lg .d :. (O 0f 7f 3. 1: )2 9 2,
1N 7e 6e 7r
g Ear -,
a" iM la y
a bn ek
yW la dt re ur
sP 2a 5rk
yR ao ha od o" .,
oBi mc h |o l Ci
H Na p :s i L,
2I 4N 2D 3O MR PE 1- 94 95 32 P0 L1 C6
( 7M 8.P 4. 0) INDIA
Date: 06" October, 2026
The DCS- Listing,
The Bombay Stock Exchange Limited,
Phiroze JeeJeebhoy Towers,
Dalal Street, Mumbai — 400 001
Script Code: 524606
Sub.: Filing of Reports for the quarter ended on 30.09.2026
Dear Sir,
With reference to various conditions stipulated under the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 and other regulation required to be complied by
the listed Companies, we are enclosing herewith the following documents for your record,
relating to quarter ended on 30th September, 2026
1. Regulation 74 (5) - Certificate under Regulation 74(5) of the SEBI (Depositories and
Participants) Regulations, 2018 for the quarter ended 30" September, 2026
2. Regulation 57(5)- Non- Applicability Certificate Under Regulation 57(5) for the quarter
ended 30 September, 2026
For Beryl Drugs Limited_
Sudhir Sethi
Chairman& Di
DIN: 00090172
adroit
‘CORPORATE SERVICES PYT LTD.
03 October 2026
BERYL DRUGS LIMITED
29, NEER NAGAR
MAYANK WATER PARK ROAD
BICHOLI (M.P.)
INDORE 452016
Subject: Confirmation Certificate in the matter of Regulation 74(5)
of Securities and Exchange Board of India (Depositories and
participants) Regulations, 2018.
Dear Sir/Madam,
In reference to the above captioned regulation,we hereby confirm that
the securities received from the depository participants for
dematerialisation during the quarter ended 30th September,2026,
were confirmed (accepted/rejected) to the depositories by us and that
securities comprised in the said certificates have been listed on the
stock exchanges where the earlier issued securities are listed.
We hereby also confirm that the security certificates received for
dematerialisation have been Mutilated and cancelled after due
verification by the depository participant and the name of the
depositories have been substituted in register of members as regist-
ered owner within 15 days.
We request you to kindly take note of the above in your records.
Thanking you,
Yours faithfully,
For Adroit Corporate Services Pvt. Ltd.
Authorized Signatory.
19-20 Jaferbhoy Industrial Estate, Makwana Road, Marol Naka, Andheri (E), Mumbai, Maharashtra, 400 059.
Tel: 022 - 4227 0400, 2859 4060. Fax: 2850 3748. Email: info@adroitcorporate.com
CIN: U67190MH1994PTC079160